Medical Devices

A new 'bioadaptor' implant that restores artery function shows an 88% drop in cardiac deaths compared to stents, heralding a new dawn for heart care.

A $290M war chest fuels a new public biotech aiming to help millions of migraine patients who don't respond to current blockbuster therapies.

The coatings giant secured John Deere's highest supplier rating and was named Supplier of the Year, signaling deep strategic partnership and market leadership.

With a $15M boost, a tech veteran's personal health crisis fuels a mission to revolutionize blood pressure monitoring for millions worldwide.

A Minnesota jury found major companies liable for a man's terminal cancer from asbestos in talc powders, highlighting a growing legal battle.

EyePromise launches Heyedrate Clinical, a new artificial tear with European-proven tech, promising longer relief for millions suffering from dry eye.

After a viral online sell-out, Korean skincare brand mixsoon is rolling into 570 Costco stores worldwide, signaling a new era for mass-market beauty.

A new partnership with AI firm Basepath Health will help Children's Mercy treat five times more children with complex and rare genetic diseases.

New FolinicActive™ offers a multi-pathway folate for the 15-25% of adults who report adverse effects from standard L-methylfolate supplements.

A new bispecific antibody, TRIV-573, enters clinical trials, targeting both skin barrier and inflammation to redefine atopic dermatitis therapy.

Beyond fat removal, a new wave of cosmetic surgery in Dubai uses advanced tech to craft athletic, natural bodies, making the city a global beauty hub.

A new partnership between Hong Kong's PAIR and the UK's Cambridge NeuroWorks aims to accelerate brain health innovations through a global seminar series.

Industry veteran Steve Motes joins Tulyp Medical as CEO, aiming to commercialize a revolutionary pressure-driven perfusion system with a proven team.

A $500K grant accelerates a novel therapy that dismantles tumor defenses, offering new hope for patients with hard-to-treat gastroesophageal cancers.

A tuition-free 'earn-and-learn' model in San Francisco offers a lifeline, turning kitchen staff into skilled nurses to combat a deepening caregiver shortage.

FDA approves the first generic of a vital nutrition drug, granting Apotex a 180-day exclusive edge and signaling major cost savings for healthcare.

Lupin has launched a generic version of the blockbuster diabetes drug Farxiga, signaling lower costs for patients and a major shake-up in the SGLT2 market.

A new partnership offers a turnkey imaging system for medical device makers, aiming to slash development time and enhance surgical precision in arthroscopy.

As labor shortages and skills gaps plague multifamily housing, a unique summit empowers the essential maintenance professionals who keep properties running.

FDA clears Allevion's Vantage™, a disposable kit with integrated visualization that targets bone growth, aiming to transform spinal decompression.